ALPINE IMMUNE SCIENCES, INC.
Related Filers (76)
- GOLD MITCHELL (27)
- Rickey James Paul (24)
- CONWAY ROBERT E (20)
- ORBIMED ADVISORS LLC (19)
- BIOTECHNOLOGY VALUE FUND L P (14)
- Thompson Peter A. (14)
- PENG STANFORD L (13)
- Topper James N (13)
- Venkatesan Jay (12)
- Alpine ImmunoSciences, L.P. (11)
- Frazier Life Sciences VIII, L.P. (11)
- Cui Xiangmin (11)
- Peetz Christopher (10)
- Flynn James E (9)
- Decheng Capital China Life Sciences USD Fund III, L.P. (9)
- Congleton Jon (7)
- OrbiMed Capital GP VI LLC (7)
- BVF PARTNERS L P/IL (6)
- BVF Partners OS Ltd. (6)
- BIOTECHNOLOGY VALUE FUND II LP (6)
- BVF INC/IL (6)
- LAMPERT MARK N (6)
- Biotechnology Value Trading Fund OS LP (6)
- Hernday Natasha (6)
- Rodman David Malcom (5)
- Carruthers R Michael (5)
- TROHA JANICE (5)
- SEKHRI PAUL J (5)
- Decheng Capital Management III (Cayman), LLC (5)
- Furst Howard P. (4)
- WELLINGTON MANAGEMENT GROUP LLP (4)
- Alpine Bioventures, GP, LLC (4)
- FHM LIFE SCIENCES VIII, L.L.C. (4)
- FHM LIFE SCIENCES VIII, L.P. (4)
- Heron Patrick J (4)
- Drappa Jorn (4)
- Avidity Partners Management LP (4)
- Estate of Arnold H. Snider, III (3)
- Jennison Global Healthcare Master Fund, Ltd. (3)
- Hawkes Bay Master Investors (Cayman) L.P. (3)
- LEFF JONATHAN S (3)
- DEERFIELD MANAGEMENT CO (3)
- Loh Evan (3)
- MOORE JOHN R (3)
- Litton Mark James (3)
- OrbiMed Genesis GP LLC (3)
- Lynx1 Capital Management LP (3)
- Sandler Andrew Seth (3)
- Omega Fund VI, L.P. (3)
- GREAT POINT PARTNERS LLC (3)
- Paradigm Biocapital Advisors LP (3)
- RA CAPITAL MANAGEMENT, L.P. (3)
- Hadley Harbor Master Investors (Cayman) L.P. (2)
- Rock Springs Capital Management LP (2)
- Deerfield Private Design Fund II, L.P. (2)
- DEERFIELD PRIVATE DESIGN FUND L P (2)
- Deerfield Special Situations Fund, L.P. (2)
- Deerfield Mgmt L.P. (2)
- Deerfield Private Design International, L.P. (2)
- Shoemaker Steven (2)
- Gabriel Sherif (2)
- ISALY SAMUEL D (2)
- TIGER MANAGEMENT L.L.C. (2)
- Goldberg Zelanna (2)
- DURAND REMY (2)
- Dummer Wolfgang (2)
- Cormorant Asset Management, LP (2)
- Deerfield Private Design International II, Ltd. (1)
- Tiger Partners GP, LLC (1)
- TIGER PARTNERS LP (1)
- Deerfield Private Design International II, L.P. (1)
- Smith Cynthia (1)
- Omega Fund IV, L.P. (1)
- Decheng Capital Global Healthcare GP, LLC (1)
- Decheng Capital Global Healthcare Fund (Master), LP (1)
- BlackRock Inc. (1)
- Show More ...
Financials (34)
10-Q
Tuesday, 11/14/2023
Quarterly Report for period ending 2023-09-30
10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Thursday, 3/23/2023
Annual Report for period ending 2022-12-31
10-Q
Monday, 11/14/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 8/11/2022
Quarterly Report for period ending 2022-06-30
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Thursday, 3/17/2022
Annual Report for period ending 2021-12-31
10-Q
Wednesday, 11/10/2021
Quarterly Report for period ending 2021-09-30
10-Q
Tuesday, 8/10/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/13/2021
Quarterly Report for period ending 2021-03-31
10-K
Thursday, 3/18/2021
Annual Report for period ending 2020-12-31
10-Q
Thursday, 11/12/2020
Quarterly Report for period ending 2020-09-30
10-Q
Tuesday, 8/11/2020
Quarterly Report for period ending 2020-06-30
10-Q
Thursday, 5/14/2020
Quarterly Report for period ending 2020-03-31
10-K
Monday, 3/30/2020
Annual Report for period ending 2019-12-31
10-Q
Thursday, 11/14/2019
Quarterly Report for period ending 2019-09-30
10-Q
Tuesday, 8/13/2019
Quarterly Report for period ending 2019-06-30
10-Q
Thursday, 5/9/2019
Quarterly Report for period ending 2019-03-31
10-K
Monday, 3/18/2019
Annual Report for period ending 2018-12-31
10-Q
Thursday, 11/8/2018
Quarterly Report for period ending 2018-09-30
10-Q
Thursday, 8/9/2018
Quarterly Report for period ending 2018-06-30
10-Q
Monday, 5/14/2018
Quarterly Report for period ending 2018-03-31
10-K
Wednesday, 3/28/2018
Annual Report for period ending 2017-12-31
10-Q
Tuesday, 11/14/2017
Quarterly Report for period ending 2017-09-30
10-Q
Friday, 7/21/2017
Quarterly Report for period ending 2017-06-30
10-Q
Tuesday, 5/2/2017
Quarterly Report for period ending 2017-03-31
10-K
Monday, 2/13/2017
Annual Report for period ending 2016-12-31
10-Q
Monday, 11/7/2016
Quarterly Report for period ending 2016-09-30
10-Q
Tuesday, 8/2/2016
Quarterly Report for period ending 2016-06-30
10-Q
Tuesday, 5/3/2016
Quarterly Report for period ending 2016-03-31
10-K
Tuesday, 3/8/2016
Annual Report for period ending 2015-12-31
10-Q
Tuesday, 11/3/2015
Quarterly Report for period ending 2015-09-30
10-Q
Tuesday, 8/4/2015
Quarterly Report for period ending 2015-06-30
News (101)
8-K
Wednesday, 2/7/2024
Current report filing
8-K
Friday, 1/5/2024
Current report filing
8-K
Thursday, 12/21/2023
Current report filing
8-K
Tuesday, 11/14/2023
Current report filing
8-K
Wednesday, 11/8/2023
Current report filing
8-K
Monday, 11/6/2023
Current report filing
8-K
Thursday, 11/2/2023
Current report filing
8-K
Monday, 8/14/2023
Current report filing
8-K
Wednesday, 6/14/2023
Current report filing
8-K
Thursday, 5/11/2023
Current report filing
8-K
Friday, 4/28/2023
Current report filing
8-K
Thursday, 3/23/2023
Current report filing
8-K
Thursday, 1/26/2023
Current report filing
8-K
Monday, 11/14/2022
Current report filing
8-K
Monday, 10/24/2022
Current report filing
8-K
Wednesday, 9/21/2022
Current report filing
8-K
Monday, 9/12/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Tuesday, 8/9/2022
Current report filing
8-K
Tuesday, 7/19/2022
Current report filing
8-K
Tuesday, 6/21/2022
Current report filing
8-K
Wednesday, 6/1/2022
Current report filing
8-K
Tuesday, 5/24/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Thursday, 3/17/2022
Current report filing
8-K
Thursday, 12/16/2021
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Wednesday, 10/13/2021
Current report filing
8-K
Wednesday, 9/15/2021
Current report filing
8-K
Tuesday, 8/10/2021
Current report filing
8-K
Friday, 7/2/2021
Current report filing
8-K
Thursday, 6/10/2021
Current report filing
8-K
Thursday, 5/13/2021
Current report filing
8-K
Thursday, 3/18/2021
Current report filing
8-K
Friday, 12/11/2020
Current report filing
8-K
Thursday, 11/12/2020
Current report filing
8-K
Tuesday, 8/11/2020
Current report filing
8-K
Friday, 7/24/2020
Current report filing
8-K
Thursday, 6/18/2020
Current report filing
8-K/A
Thursday, 6/18/2020
Current report filing
8-K
Wednesday, 6/17/2020
Current report filing
8-K
Thursday, 5/14/2020
Current report filing
8-K
Monday, 3/30/2020
Current report filing
8-K
Monday, 1/27/2020
Current report filing
8-K
Wednesday, 11/13/2019
Current report filing
8-K
Wednesday, 8/28/2019
Current report filing
8-K
Tuesday, 8/13/2019
Current report filing
8-K
Monday, 6/17/2019
Current report filing
8-K
Friday, 5/24/2019
Current report filing
8-K
Wednesday, 5/15/2019
Current report filing
8-K
Thursday, 5/9/2019
Current report filing
8-K
Thursday, 4/18/2019
Current report filing
8-K
Monday, 4/1/2019
Current report filing
8-K
Monday, 3/18/2019
Current report filing
8-K
Friday, 2/8/2019
Current report filing
8-K
Friday, 1/18/2019
Current report filing
8-K
Wednesday, 1/16/2019
Current report filing
8-K
Thursday, 11/8/2018
Current report filing
8-K
Tuesday, 9/25/2018
Current report filing
8-K
Thursday, 8/9/2018
Current report filing
8-K
Monday, 8/6/2018
Current report filing
8-K
Thursday, 6/14/2018
Current report filing
8-K
Monday, 6/11/2018
Current report filing
8-K
Monday, 5/14/2018
Current report filing
8-K
Tuesday, 4/24/2018
Current report filing
8-K
Wednesday, 3/28/2018
Current report filing
8-K
Monday, 12/11/2017
Current report filing
8-K
Monday, 11/13/2017
Current report filing
8-K
Tuesday, 10/24/2017
Current report filing
8-K/A
Friday, 9/29/2017
Current report filing
8-K
Tuesday, 7/25/2017
Current report filing
8-K
Thursday, 7/20/2017
Current report filing
8-K
Friday, 6/2/2017
Current report filing
8-K
Wednesday, 5/17/2017
Current report filing
8-K
Monday, 5/1/2017
Current report filing
8-K
Friday, 4/28/2017
Current report filing
8-K
Tuesday, 4/18/2017
Current report filing
8-K
Thursday, 2/23/2017
Current report filing
8-K
Monday, 2/13/2017
Current report filing
8-K
Thursday, 1/12/2017
Current report filing
8-K
Wednesday, 1/4/2017
Current report filing
8-K
Monday, 11/28/2016
Current report filing
8-K
Monday, 11/14/2016
Current report filing
8-K
Monday, 11/7/2016
Current report filing
8-K
Thursday, 11/3/2016
Current report filing
8-K
Monday, 8/1/2016
Current report filing
8-K
Thursday, 7/7/2016
Current report filing
8-K
Monday, 5/16/2016
Current report filing
8-K
Monday, 5/2/2016
Current report filing
8-K
Monday, 5/2/2016
Current report filing
8-K
Friday, 4/22/2016
Current report filing
8-K
Tuesday, 4/5/2016
Current report filing
8-K
Monday, 3/7/2016
Current report filing
8-K
Monday, 2/29/2016
Current report filing
8-K
Thursday, 2/18/2016
Current report filing
8-K
Tuesday, 1/26/2016
Current report filing
8-K
Friday, 1/15/2016
Current report filing
8-K
Tuesday, 12/1/2015
Current report filing
8-K
Monday, 11/2/2015
Current report filing
8-K
Wednesday, 10/7/2015
Current report filing
Other (47)
144
Friday, 1/26/2024
Filing for proposed sale of securities under Rule 144
144
Thursday, 1/25/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/27/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/27/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/19/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 12/15/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 12/14/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 12/8/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 11/6/2023
Filing for proposed sale of securities under Rule 144
EFFECT
Wednesday, 8/16/2023
Notice of Effectiveness
POS AM
Monday, 8/14/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
EFFECT
Tuesday, 5/9/2023
Notice of Effectiveness
CORRESP
Friday, 5/5/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
ARS
Thursday, 4/27/2023
Annual report to security holders
CT ORDER
Wednesday, 3/23/2022
Order Granting Confidential Treatment
CT ORDER
Wednesday, 3/23/2022
Order Granting Confidential Treatment
EFFECT
Friday, 11/19/2021
Notice of Effectiveness
CORRESP
Wednesday, 11/17/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 9/30/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Wednesday, 9/29/2021
Exempt (Private) Offering
EFFECT
Thursday, 5/20/2021
Notice of Effectiveness
CORRESP
Tuesday, 5/18/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Tuesday, 5/18/2021
Notice of Effectiveness
EFFECT
Tuesday, 5/18/2021
Notice of Effectiveness
POS AM
Friday, 5/14/2021
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Friday, 5/14/2021
Post-effective amendment to a registration statement that is not immediately effective upon filing
EFFECT
Tuesday, 8/18/2020
Notice of Effectiveness
CORRESP
Friday, 8/14/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Friday, 8/7/2020
Exempt (Private) Offering
EFFECT
Thursday, 7/16/2020
Notice of Effectiveness
CORRESP
Tuesday, 7/14/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 4/4/2019
Notice of Effectiveness
CORRESP
Tuesday, 4/2/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Friday, 3/29/2019
Order Granting Confidential Treatment
CT ORDER
Tuesday, 3/19/2019
Order Granting Confidential Treatment
D
Wednesday, 1/30/2019
Exempt (Private) Offering
CT ORDER
Tuesday, 12/5/2017
Order Granting Confidential Treatment
EFFECT
Tuesday, 6/6/2017
Notice of Effectiveness
CORRESP
Friday, 6/2/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 7/14/2016
Notice of Effectiveness
CORRESP
Wednesday, 7/13/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Tuesday, 6/16/2015
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERTNAS
Tuesday, 6/16/2015
None
EFFECT
Tuesday, 6/16/2015
Notice of Effectiveness
CORRESP
Friday, 6/12/2015
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 5/19/2015
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Tuesday, 11/25/2014
Exempt (Private) Offering
Ownership (317)
SC 13G/A
Wednesday, 2/14/2024
GREAT POINT PARTNERS LLC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Lynx1 Capital Management LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Omega Fund VI, L.P.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cormorant Asset Management, LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Paradigm Biocapital Advisors LP: Major Shareholders
SC 13G
Friday, 2/2/2024
BlackRock Inc.: Major Shareholders
4
Monday, 1/29/2024
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Monday, 1/22/2024
Cui Xiangmin: Statement of changes in beneficial ownership of securities
4
Monday, 1/22/2024
Decheng Capital China Life Sciences USD Fund III, L.P.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2024
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2024
Thompson Peter A.: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
PENG STANFORD L: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
DURAND REMY: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
CONWAY ROBERT E: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
Peetz Christopher: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
Cui Xiangmin: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
Topper James N: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
Hernday Natasha: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
Thompson Peter A.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
Drappa Jorn: Statement of changes in beneficial ownership of securities
4
Friday, 12/29/2023
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Friday, 12/29/2023
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Friday, 12/29/2023
Thompson Peter A.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 12/29/2023
ORBIMED ADVISORS LLC: Major Shareholders
4
Wednesday, 12/27/2023
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Thursday, 12/21/2023
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Thursday, 12/21/2023
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Monday, 12/18/2023
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2023
Topper James N: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/6/2023
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Friday, 12/1/2023
Rickey James Paul: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 11/22/2023
Frazier Life Sciences VIII, L.P.: Major Shareholders
SC 13D/A
Tuesday, 11/14/2023
Alpine ImmunoSciences, L.P.: Major Shareholders
SC 13D/A
Tuesday, 11/14/2023
Decheng Capital China Life Sciences USD Fund III, L.P.: Major Shareholders
4
Tuesday, 11/14/2023
Cui Xiangmin: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/14/2023
Decheng Capital Global Healthcare Fund (Master), LP: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 11/13/2023
ORBIMED ADVISORS LLC: Major Shareholders
4
Wednesday, 11/8/2023
Rickey James Paul: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/23/2023
Cormorant Asset Management, LP: Major Shareholders
3
Wednesday, 10/4/2023
Dummer Wolfgang: Initial statement of beneficial ownership of securities
4
Wednesday, 10/4/2023
Dummer Wolfgang: Statement of changes in beneficial ownership of securities
3
Thursday, 4/27/2023
DURAND REMY: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Paradigm Biocapital Advisors LP: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
GREAT POINT PARTNERS LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Avidity Partners Management LP: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Lynx1 Capital Management LP: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Omega Fund VI, L.P.: Major Shareholders
4
Thursday, 1/5/2023
Hernday Natasha: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Drappa Jorn: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Topper James N: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Thompson Peter A.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Cui Xiangmin: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Sandler Andrew Seth: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
PENG STANFORD L: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
CONWAY ROBERT E: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Peetz Christopher: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/3/2022
Paradigm Biocapital Advisors LP: Major Shareholders
SC 13G
Monday, 10/3/2022
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G
Friday, 9/30/2022
GREAT POINT PARTNERS LLC: Major Shareholders
SC 13D/A
Tuesday, 9/27/2022
Decheng Capital China Life Sciences USD Fund III, L.P.: Major Shareholders
SC 13D/A
Tuesday, 9/27/2022
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Tuesday, 9/27/2022
Alpine ImmunoSciences, L.P.: Major Shareholders
4
Tuesday, 9/27/2022
Decheng Capital China Life Sciences USD Fund III, L.P.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/27/2022
Cui Xiangmin: Statement of changes in beneficial ownership of securities
4
Thursday, 8/18/2022
Sandler Andrew Seth: Statement of changes in beneficial ownership of securities
3
Thursday, 8/18/2022
Sandler Andrew Seth: Initial statement of beneficial ownership of securities
3
Tuesday, 7/19/2022
Drappa Jorn: Initial statement of beneficial ownership of securities
4
Tuesday, 7/19/2022
Drappa Jorn: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/19/2022
Venkatesan Jay: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 4/22/2022
Lynx1 Capital Management LP: Major Shareholders
SC 13D/A
Tuesday, 2/15/2022
Frazier Life Sciences VIII, L.P.: Major Shareholders
4
Tuesday, 2/15/2022
Topper James N: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Omega Fund VI, L.P.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Avidity Partners Management LP: Major Shareholders
SC 13G/A
Monday, 2/14/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Monday, 2/14/2022
Decheng Capital Management III (Cayman), LLC: Major Shareholders
4
Thursday, 1/6/2022
PENG STANFORD L: Statement of changes in beneficial ownership of securities
4
Thursday, 1/6/2022
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Thursday, 1/6/2022
GOLD MITCHELL: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Topper James N: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Peetz Christopher: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
CONWAY ROBERT E: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Hernday Natasha: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Rickey James Paul: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Venkatesan Jay: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Cui Xiangmin: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Thompson Peter A.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 11/12/2021
ORBIMED ADVISORS LLC: Major Shareholders
4/A
Monday, 9/27/2021
CONWAY ROBERT E: Statement of changes in beneficial ownership of securities
4/A
Monday, 9/27/2021
Peetz Christopher: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
Peetz Christopher: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
CONWAY ROBERT E: Statement of changes in beneficial ownership of securities
Prospectus (49)
424B5
Wednesday, 11/8/2023
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Tuesday, 11/7/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Monday, 11/6/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 5/11/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Friday, 4/28/2023
Registration statement for specified transactions by certain issuers
S-8
Thursday, 3/23/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 3/23/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Wednesday, 9/21/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 9/20/2022
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Thursday, 3/17/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Monday, 11/22/2021
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Wednesday, 11/10/2021
Registration statement for specified transactions by certain issuers
S-8
Tuesday, 8/10/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 7/2/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Thursday, 5/20/2021
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Friday, 5/14/2021
Registration statement for specified transactions by certain issuers
S-8
Thursday, 3/18/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Wednesday, 8/19/2020
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Tuesday, 8/11/2020
General form of registration statement for all companies including face-amount certificate companies
S-3
Wednesday, 7/8/2020
Registration statement for specified transactions by certain issuers
S-8
Wednesday, 6/17/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 3/30/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Friday, 4/5/2019
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Monday, 3/18/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 3/18/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-1
Monday, 3/18/2019
General form of registration statement for all companies including face-amount certificate companies
S-8
Thursday, 6/21/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 6/11/2018
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Wednesday, 3/28/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Monday, 9/11/2017
Post-effective amendment to a S-8 registration statement
424B3
Tuesday, 6/6/2017
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Friday, 6/2/2017
Registration of securities issued in business combination transactions
425
Friday, 6/2/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-4
Friday, 5/19/2017
Registration of securities issued in business combination transactions
425
Friday, 4/28/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 4/19/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 4/18/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-3
Wednesday, 7/6/2016
Registration statement for specified transactions by certain issuers
S-8
Friday, 5/6/2016
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 6/25/2015
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Wednesday, 6/17/2015
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Tuesday, 6/16/2015
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Wednesday, 6/3/2015
General form of registration statement for all companies including face-amount certificate companies
S-1
Wednesday, 5/13/2015
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Wednesday, 4/8/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Wednesday, 4/8/2015
Correspondence Related to Draft Registration Statement
DRS/A
Wednesday, 3/18/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 3/17/2015
Correspondence Related to Draft Registration Statement
DRS
Friday, 2/13/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (16)
DEFA14A
Thursday, 4/27/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/27/2023
Definitive proxy statements
PRE 14A
Friday, 4/14/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Friday, 4/29/2022
Definitive proxy statements
DEFA14A
Friday, 4/29/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 4/29/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/29/2021
Definitive proxy statements
DEF 14A
Tuesday, 5/5/2020
Definitive proxy statements
DEFA14A
Tuesday, 5/5/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Wednesday, 4/24/2019
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/24/2019
Definitive proxy statements
PRE 14A
Thursday, 4/11/2019
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Tuesday, 4/24/2018
Definitive proxy statements
DEFA14A
Tuesday, 4/24/2018
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/6/2017
Definitive proxy statements
DEF 14A
Monday, 3/21/2016
Definitive proxy statements